TickerFacts.

Monopar Therapeutics (MNPR): Share Repurchases

Annual figures by period end, from SEC filings.

$35.00M
Year ended 2025-12-31
2024-12-31: $02025-12-31: $35.00M$35.00M
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$35.00Mn/a2026-03-27, From 2025-01-01
2024-12-31$0n/a2026-03-27, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Monopar Therapeutics (MNPR)2025-12-31$35.00Mn/a
Abbott Laboratories (ABT)2025-12-31$893.00M-31.0%
Bristol Myers Squibb Co (BMY)2025-12-31$0n/a
Eli Lilly & Co (LLY)2025-12-31$4.11B+64.3%
Pfizer Inc (PFE)2024-12-31$0n/a
Johnson & Johnson (JNJ)2025-12-28$5.95B+144.8%
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
Merck & Co., Inc. (MRK)2025-12-31$5.08B+289.3%
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%

Compare MNPR, ABT, BMY, LLY side by side · Screen every company in Pharmaceutical Preparations ↗